APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diabetic Macular Edema Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Diabetic Macular Edema Drug Industry Growth and Trends Forecast to 2032

19 December 202599 pages

Choose your research edition.

Industry ResearchDiabetic Macular Edema Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Diabetic Macular Edema Drug Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Diabetic Macular Edema Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diabetic Macular Edema Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Diabetic Macular Edema Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Diabetic Macular Edema Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Diabetic Macular Edema Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Diabetic Macular Edema Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diabetic Macular Edema Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Diabetic Macular Edema Drug include Novartis, Bayer, Valeant, Hoffman-La Roche, Allergan and Alimera, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Diabetic Macular Edema Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Diabetic Macular Edema Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Diabetic Macular Edema Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Diabetic Macular Edema Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Diabetic Macular Edema Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Diabetic Macular Edema Drug Market by Company

Novartis

Bayer

Valeant

Hoffman-La Roche

Allergan

Alimera

Diabetic Macular Edema Drug Segment by Type

Intravitreal Injections

Intravitreal Implants

Diabetic Macular Edema Drug Segment by Application

Anti-VEGF

Corticosteroids

Others

Diabetic Macular Edema Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetic Macular Edema Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diabetic Macular Edema Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetic Macular Edema Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Diabetic Macular Edema Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Diabetic Macular Edema Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Intravitreal Injections Table 2. Major Company of Intravitreal Implants Table 3. Global Diabetic Macular Edema Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Diabetic Macular Edema Drug Sales by Type (2021-2026) & (K Units) Table 5. Global Diabetic Macular Edema Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Diabetic Macular Edema Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Diabetic Macular Edema Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Diabetic Macular Edema Drug Price by Type (2021-2026) & (US$/Unit) Table 9. Global Diabetic Macular Edema Drug Sales by Type (2027-2032) & (K Units) Table 10. Global Diabetic Macular Edema Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Diabetic Macular Edema Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Diabetic Macular Edema Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Diabetic Macular Edema Drug Price by Type (2027-2032) & (US$/Unit) Table 14. North America Diabetic Macular Edema Drug Sales by Type (2021-2026) & (K Units) Table 15. North America Diabetic Macular Edema Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Diabetic Macular Edema Drug Sales by Type (2021-2026) & (K Units) Table 17. Europe Diabetic Macular Edema Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Diabetic Macular Edema Drug Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Diabetic Macular Edema Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Diabetic Macular Edema Drug Sales by Type (2021-2026) & (K Units) Table 21. Latin America Diabetic Macular Edema Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Diabetic Macular Edema Drug Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Diabetic Macular Edema Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Diabetic Macular Edema Drug Industry Trends Table 25. Diabetic Macular Edema Drug Industry Drivers Table 26. Diabetic Macular Edema Drug Industry Opportunities and Challenges Table 27. Diabetic Macular Edema Drug Industry Restraints Table 28. Global Diabetic Macular Edema Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Diabetic Macular Edema Drug Revenue Market Share by Company (2021-2026) Table 30. Global Diabetic Macular Edema Drug Sales by Company (2021-2026) & (K Units) Table 31. Global Diabetic Macular Edema Drug Sales Share by Company (2021-2026) Table 32. Global Diabetic Macular Edema Drug Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Diabetic Macular Edema Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Diabetic Macular Edema Drug Major Company Production Sites and Headquarters Table 35. Global Diabetic Macular Edema Drug Company, Product Type & Application Table 36. Global Diabetic Macular Edema Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Diabetic Macular Edema Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Diabetic Macular Edema Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Diabetic Macular Edema Drug Sales by Region (2021-2026) & (K Units) Table 41. Global Diabetic Macular Edema Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Diabetic Macular Edema Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Diabetic Macular Edema Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Diabetic Macular Edema Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Diabetic Macular Edema Drug Sales by Region (2027-2032) & (K Units) Table 46. Global Diabetic Macular Edema Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Diabetic Macular Edema Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Diabetic Macular Edema Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Diabetic Macular Edema Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Diabetic Macular Edema Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Diabetic Macular Edema Drug Sales by Application (2021-2026) & (K Units) Table 52. Global Diabetic Macular Edema Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Diabetic Macular Edema Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Diabetic Macular Edema Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Diabetic Macular Edema Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Diabetic Macular Edema Drug Sales by Application (2027-2032) & (K Units) Table 57. Global Diabetic Macular Edema Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Diabetic Macular Edema Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Diabetic Macular Edema Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Diabetic Macular Edema Drug Price by Application (2027-2032) & (US$/Unit) Table 61. North America Diabetic Macular Edema Drug Sales by Application (2021-2026) & (K Units) Table 62. North America Diabetic Macular Edema Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Diabetic Macular Edema Drug Sales by Application (2021-2026) & (K Units) Table 64. Europe Diabetic Macular Edema Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Diabetic Macular Edema Drug Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Diabetic Macular Edema Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Diabetic Macular Edema Drug Sales by Application (2021-2026) & (K Units) Table 68. Latin America Diabetic Macular Edema Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Diabetic Macular Edema Drug Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Diabetic Macular Edema Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Diabetic Macular Edema Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Novartis Diabetic Macular Edema Drug Product Portfolio Table 75. Novartis Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer Diabetic Macular Edema Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bayer Diabetic Macular Edema Drug Product Portfolio Table 80. Bayer Recent Development Table 81. Valeant Company Information Table 82. Valeant Business Overview Table 83. Valeant Diabetic Macular Edema Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Valeant Diabetic Macular Edema Drug Product Portfolio Table 85. Valeant Recent Development Table 86. Hoffman-La Roche Company Information Table 87. Hoffman-La Roche Business Overview Table 88. Hoffman-La Roche Diabetic Macular Edema Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Hoffman-La Roche Diabetic Macular Edema Drug Product Portfolio Table 90. Hoffman-La Roche Recent Development Table 91. Allergan Company Information Table 92. Allergan Business Overview Table 93. Allergan Diabetic Macular Edema Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Allergan Diabetic Macular Edema Drug Product Portfolio Table 95. Allergan Recent Development Table 96. Alimera Company Information Table 97. Alimera Business Overview Table 98. Alimera Diabetic Macular Edema Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Alimera Diabetic Macular Edema Drug Product Portfolio Table 100. Alimera Recent Development Table 101. North America Diabetic Macular Edema Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Diabetic Macular Edema Drug Sales by Country (2021-2026) & (K Units) Table 103. North America Diabetic Macular Edema Drug Sales Market Share by Country (2021-2026) Table 104. North America Diabetic Macular Edema Drug Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Diabetic Macular Edema Drug Sales Market Share Forecast by Country (2027-2032) Table 106. North America Diabetic Macular Edema Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Diabetic Macular Edema Drug Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Diabetic Macular Edema Drug Market Share by Country (2021-2026) Table 109. North America Diabetic Macular Edema Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Diabetic Macular Edema Drug Market Share Forecast by Country (2027-2032) Table 111. Europe Diabetic Macular Edema Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Diabetic Macular Edema Drug Sales by Country (2021-2026) & (K Units) Table 113. Europe Diabetic Macular Edema Drug Sales Market Share by Country (2021-2026) Table 114. Europe Diabetic Macular Edema Drug Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Diabetic Macular Edema Drug Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Diabetic Macular Edema Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Diabetic Macular Edema Drug Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Diabetic Macular Edema Drug Market Share by Country (2021-2026) Table 119. Europe Diabetic Macular Edema Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Diabetic Macular Edema Drug Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Diabetic Macular Edema Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Diabetic Macular Edema Drug Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Diabetic Macular Edema Drug Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Diabetic Macular Edema Drug Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Diabetic Macular Edema Drug Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Diabetic Macular Edema Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Diabetic Macular Edema Drug Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Diabetic Macular Edema Drug Market Share by Country (2021-2026) Table 129. Asia-Pacific Diabetic Macular Edema Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Diabetic Macular Edema Drug Market Share Forecast by Country (2027-2032) Table 131. Latin America Diabetic Macular Edema Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Diabetic Macular Edema Drug Sales by Country (2021-2026) & (K Units) Table 133. Latin America Diabetic Macular Edema Drug Sales Market Share by Country (2021-2026) Table 134. Latin America Diabetic Macular Edema Drug Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Diabetic Macular Edema Drug Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Diabetic Macular Edema Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Diabetic Macular Edema Drug Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Diabetic Macular Edema Drug Market Share by Country (2021-2026) Table 139. Latin America Diabetic Macular Edema Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Diabetic Macular Edema Drug Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Diabetic Macular Edema Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Diabetic Macular Edema Drug Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Diabetic Macular Edema Drug Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Diabetic Macular Edema Drug Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Diabetic Macular Edema Drug Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Diabetic Macular Edema Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Diabetic Macular Edema Drug Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Diabetic Macular Edema Drug Market Share by Country (2021-2026) Table 149. Middle East and Africa Diabetic Macular Edema Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Diabetic Macular Edema Drug Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Diabetic Macular Edema Drug Distributors List Table 154. Diabetic Macular Edema Drug Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Diabetic Macular Edema Drug Image Figure 2. Global Diabetic Macular Edema Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diabetic Macular Edema Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Diabetic Macular Edema Drug Sales (2021-2032) & (K Units) Figure 5. Intravitreal Injections Image Figure 6. Global Intravitreal Injections Sales YoY Growth (2021-2032) & (K Units) Figure 7. Intravitreal Implants Image Figure 8. Global Intravitreal Implants Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Diabetic Macular Edema Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Diabetic Macular Edema Drug Market Share by Type 2025 VS 2032 Figure 11. North America Diabetic Macular Edema Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Diabetic Macular Edema Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Diabetic Macular Edema Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Diabetic Macular Edema Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Diabetic Macular Edema Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Diabetic Macular Edema Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Diabetic Macular Edema Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Diabetic Macular Edema Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Diabetic Macular Edema Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Diabetic Macular Edema Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Diabetic Macular Edema Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Anti-VEGF Image Figure 24. Global Anti-VEGF Sales YoY Growth (2021-2032) & (K Units) Figure 25. Corticosteroids Image Figure 26. Global Corticosteroids Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Diabetic Macular Edema Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Diabetic Macular Edema Drug Market Share by Application 2025 VS 2032 Figure 31. North America Diabetic Macular Edema Drug Sales Market Share in Volume by Application in 2025 Figure 32. North America Diabetic Macular Edema Drug Sales Market Share in Value by Application in 2025 Figure 33. Europe Diabetic Macular Edema Drug Sales Market Share in Volume by Application in 2025 Figure 34. Europe Diabetic Macular Edema Drug Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Diabetic Macular Edema Drug Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Diabetic Macular Edema Drug Sales Market Share in Value by Application in 2025 Figure 37. Latin America Diabetic Macular Edema Drug Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Diabetic Macular Edema Drug Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Diabetic Macular Edema Drug Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Diabetic Macular Edema Drug Sales Market Share in Value by Application in 2025 Figure 41. North America Diabetic Macular Edema Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Diabetic Macular Edema Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Diabetic Macular Edema Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Diabetic Macular Edema Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Diabetic Macular Edema Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Diabetic Macular Edema Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Diabetic Macular Edema Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Diabetic Macular Edema Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Diabetic Macular Edema Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Diabetic Macular Edema Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Diabetic Macular Edema Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Diabetic Macular Edema Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Diabetic Macular Edema Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Diabetic Macular Edema Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Diabetic Macular Edema Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Diabetic Macular Edema Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Diabetic Macular Edema Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Diabetic Macular Edema Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Diabetic Macular Edema Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Diabetic Macular Edema Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Diabetic Macular Edema Drug Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Diabetic Macular Edema Drug Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Intravitreal Injections
  • Intravitreal Implants
Applications
  • Anti-VEGF
  • Corticosteroids
  • Others
Companies covered
  • Novartis
  • Bayer
  • Valeant
  • Hoffman-La Roche
  • Allergan
  • Alimera

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Diabetic Macular Edema Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Diabetic Macular Edema Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Diabetic Macular Edema Drug Market by Type
  6. 1.3.1 Intravitreal Injections
  7. 1.3.2 Intravitreal Implants
  8. 1.4 Global Diabetic Macular Edema Drug Market Size by Type
  9. 1.4.1 Global Diabetic Macular Edema Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Diabetic Macular Edema Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Diabetic Macular Edema Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Diabetic Macular Edema Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Diabetic Macular Edema Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Diabetic Macular Edema Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Diabetic Macular Edema Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Diabetic Macular Edema Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Diabetic Macular Edema Drug Industry Trends
  2. 2.2 Diabetic Macular Edema Drug Industry Drivers
  3. 2.3 Diabetic Macular Edema Drug Industry Opportunities and Challenges
  4. 2.4 Diabetic Macular Edema Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Diabetic Macular Edema Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Diabetic Macular Edema Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Diabetic Macular Edema Drug Price (2021-2026)
  4. 3.4 Global Diabetic Macular Edema Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Diabetic Macular Edema Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Diabetic Macular Edema Drug Company, Product Type & Application
  7. 3.7 Global Diabetic Macular Edema Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Diabetic Macular Edema Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Diabetic Macular Edema Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Diabetic Macular Edema Drug Tier 1, Tier 2, and Tier 3
4 Diabetic Macular Edema Drug Regional Status and Outlook
  1. 4.1 Global Diabetic Macular Edema Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Diabetic Macular Edema Drug Historic Market Size by Region
  3. 4.2.1 Global Diabetic Macular Edema Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Diabetic Macular Edema Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Diabetic Macular Edema Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Diabetic Macular Edema Drug Forecasted Market Size by Region
  7. 4.3.1 Global Diabetic Macular Edema Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Diabetic Macular Edema Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Diabetic Macular Edema Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Diabetic Macular Edema Drug by Application
  1. 5.1 Diabetic Macular Edema Drug Market by Application
  2. 5.1.1 Anti-VEGF
  3. 5.1.2 Corticosteroids
  4. 5.1.3 Others
  5. 5.2 Global Diabetic Macular Edema Drug Market Size by Application
  6. 5.2.1 Global Diabetic Macular Edema Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Diabetic Macular Edema Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Diabetic Macular Edema Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Diabetic Macular Edema Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Diabetic Macular Edema Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Diabetic Macular Edema Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Diabetic Macular Edema Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Diabetic Macular Edema Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Diabetic Macular Edema Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Diabetic Macular Edema Drug Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Bayer
  8. 6.2.1 Bayer Company Information
  9. 6.2.2 Bayer Business Overview
  10. 6.2.3 Bayer Diabetic Macular Edema Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer Diabetic Macular Edema Drug Product Portfolio
  12. 6.2.5 Bayer Recent Developments
  13. 6.3 Valeant
  14. 6.3.1 Valeant Company Information
  15. 6.3.2 Valeant Business Overview
  16. 6.3.3 Valeant Diabetic Macular Edema Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Valeant Diabetic Macular Edema Drug Product Portfolio
  18. 6.3.5 Valeant Recent Developments
  19. 6.4 Hoffman-La Roche
  20. 6.4.1 Hoffman-La Roche Company Information
  21. 6.4.2 Hoffman-La Roche Business Overview
  22. 6.4.3 Hoffman-La Roche Diabetic Macular Edema Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hoffman-La Roche Diabetic Macular Edema Drug Product Portfolio
  24. 6.4.5 Hoffman-La Roche Recent Developments
  25. 6.5 Allergan
  26. 6.5.1 Allergan Company Information
  27. 6.5.2 Allergan Business Overview
  28. 6.5.3 Allergan Diabetic Macular Edema Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Allergan Diabetic Macular Edema Drug Product Portfolio
  30. 6.5.5 Allergan Recent Developments
  31. 6.6 Alimera
  32. 6.6.1 Alimera Company Information
  33. 6.6.2 Alimera Business Overview
  34. 6.6.3 Alimera Diabetic Macular Edema Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Alimera Diabetic Macular Edema Drug Product Portfolio
  36. 6.6.5 Alimera Recent Developments
7 North America by Country
  1. 7.1 North America Diabetic Macular Edema Drug Sales by Country
  2. 7.1.1 North America Diabetic Macular Edema Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Diabetic Macular Edema Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Diabetic Macular Edema Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Diabetic Macular Edema Drug Market Size by Country
  6. 7.2.1 North America Diabetic Macular Edema Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Diabetic Macular Edema Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Diabetic Macular Edema Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Diabetic Macular Edema Drug Sales by Country
  2. 8.1.1 Europe Diabetic Macular Edema Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Diabetic Macular Edema Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Diabetic Macular Edema Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Diabetic Macular Edema Drug Market Size by Country
  6. 8.2.1 Europe Diabetic Macular Edema Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Diabetic Macular Edema Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Diabetic Macular Edema Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Diabetic Macular Edema Drug Sales by Country
  2. 9.1.1 Asia-Pacific Diabetic Macular Edema Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Diabetic Macular Edema Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Diabetic Macular Edema Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Diabetic Macular Edema Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Diabetic Macular Edema Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Diabetic Macular Edema Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Diabetic Macular Edema Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Diabetic Macular Edema Drug Sales by Country
  2. 10.1.1 South America Diabetic Macular Edema Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Diabetic Macular Edema Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Diabetic Macular Edema Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Diabetic Macular Edema Drug Market Size by Country
  6. 10.2.1 South America Diabetic Macular Edema Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Diabetic Macular Edema Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Diabetic Macular Edema Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Diabetic Macular Edema Drug Sales by Country
  2. 11.1.1 Middle East and Africa Diabetic Macular Edema Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Diabetic Macular Edema Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Diabetic Macular Edema Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Diabetic Macular Edema Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Diabetic Macular Edema Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Diabetic Macular Edema Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Diabetic Macular Edema Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Diabetic Macular Edema Drug Value Chain Analysis
  2. 12.1.1 Diabetic Macular Edema Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Diabetic Macular Edema Drug Production Mode & Process
  7. 12.2 Diabetic Macular Edema Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Diabetic Macular Edema Drug Distributors
  10. 12.2.3 Diabetic Macular Edema Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst